Latest Elekta Stories

Linear accelerator is island's first Versa HD PONCE, Puerto Rico, May 17, 2013 /PRNewswire/ -- Serving a region of 650,000 inhabitants in southern, central and western Puerto Rico, Caribbean Imaging and Radiation Therapy (CIRT, Ponce, PR) Center has improved its radiation therapy capabilities with the acquisition of an Elekta Versa HD(TM) system, the first in Puerto Rico. Versa HD offers clinicians the versatility to deliver conventional therapies to treat a wide range of tumors...

[311 Pages Report] The Radiotherapy Devices Market Report segments global market of Monitoring Devices by various technologies Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Cyber knife, Gamma knife, Proton / Neutron Therapy, Dynamic Multi-Leaf Collimator (DMLC) and by Geography (PRWEB) May 10, 2013 The “Radiotherapy Market By Technology, Applications & Products (2011 – 2016)”, published by MarketsandMarkets analyzes and studies the major...

Research projects to have implications for cancer treatment worldwide TORONTO, May 10, 2013 /PRNewswire/ -- Elekta (NSE: EKTAb) and Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced today that Sunnybrook Health Sciences Centre (Toronto, Canada) will join their growing consortium to validate the clinical potential of MRI-guided radiation therapy. Sunnybrook Health Sciences Centre, the sixth largest cancer center in North America, is the fourth member to sign the research...

NEW ORLEANS, April 25, 2013 /PRNewswire/ -- At the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting April 27-May 1 at the Ernest N. Morial Convention Center, Elekta (booth #2239) will spotlight the continuing preeminence of Gamma Knife® stereotactic radiosurgery (SRS) as the gold standard for treating benign and malignant brain tumors, plus other functional and vascular brain disorders. "As the only radiosurgery device designed and dedicated to...

GENEVA, April 22, 2013 /PRNewswire/ -- Better outcomes can be achieved for prostate cancer patients using brachytherapy, a highly targeted form of radiotherapy, compared to surgery - this is the finding of a new study conducted by PANAXEA, The University of Twente, Netherlands.(1) The study, which will be presented at the European Society for Radiotherapy and Oncology (ESTRO) 19-23 April 2013, Geneva, Switzerland used the latest cost effectiveness model to look at relevant recent...

New system sets benchmark in radiation oncology versatility and capabilities HOUSTON, April 18, 2013 /PRNewswire/ -- The University of Texas MD Anderson Cancer Center (Houston, Texas) has purchased two Elekta Versa HD(TM) linear accelerators. The radiation therapy system, which recently received 510(k) clearance from the U.S. Food and Drug Administration, features the versatility to deliver high-volume conventional techniques, in addition to the most advanced linear-accelerator...

Newly released brachytherapy delivery process features logical workflow and intuitive system operation for greater user and patient safety NEW ORLEANS, April 18, 2013 /PRNewswire/ -- At the 2013 American Brachytherapy Society (ABS) meeting April 18-20 in New Orleans, Nucletron, an Elekta company, (booth #300), will introduce its newly redesigned Flexitron® remote afterloading platform. Flexitron emphasizes safety and efficiency in the brachytherapy workflow, increasing the...

Latest Elekta linear accelerator sets benchmark in radiation oncology versatility and capabilities GENEVA, April 15, 2013 /PRNewswire/ -- ESTRO Booth #3400 - Elekta will debut its Versa HD(TM) system at the first major exhibition since the company introduced the advanced linear accelerator globally on March 1. The 2(nd) ESTRO (European Society for Radiotherapy and Oncology) Forum convenes April 19-23 at the Palexpo convention center in Geneva. Versa HD features high-precision beam...

Groundbreaking linear accelerator provides single system versatility to deliver sophisticated treatments for more patients and cancer types ATLANTA, April 11, 2013 /PRNewswire/ -- Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD(TM) system within the United States. Featuring high precision beam shaping and tumor targeting, and capable of delivering...

The Christie NHS Foundation Trust to harness new linear accelerator to improve therapy for patients with head-and-neck, lung and prostate cancers MANCHESTER, England, April 10, 2013 /PRNewswire/ -- Featuring a revolutionary combination of speed and accuracy, Elekta's new Versa HD(TM) system will help clinicians at The Christie NHS Foundation Trust (Withington, Manchester) maximize the precision of therapeutic beams on the tumor target, while also accelerating radiation delivery to...